News 1 June 2026

Etihad Orders 10 Boeing Jets, Raising Talk of Hard-to-Get 787 Slots
·······

Stock Market Today: Live Updates 13.07.2026

LIVEMarkets rolling coverageStarted: July 13, 2026, 4:00 AM EDTUpdated: July 13, 2026, 8:04 AM EDT Allianz Global Investors Reveals 2.03% Holding in DCC PLC July 13, 2026, 8:04 AM EDT. Allianz Global Investors reported a 2.03% stake (1,731,025 shares) in DCC PLC in a Form 8.3 filed on 13 July 2026. The filing, made under the Irish Takeover Panel Act, 1997, shows AllianzGI held over 1% in DCC’s ordinary shares as of 10 July 2026. No shorts or derivatives in DCC were reported. AllianzGI said it does not control votes for some of these shares. The move keeps the market
July 13, 2026
GDEV Stock Draws Attention During Thin Small-Cap Gaming Trade
····

GDEV Stock Draws Attention During Thin Small-Cap Gaming Trade

GDEV Inc traded around $14.41 Monday in thin Nasdaq action, holding near the bottom of its 52-week range. The small-cap gaming stock saw just 2,468 shares cross, with investors tracking a stronger first-quarter profit but noting slower user growth. Volume was light for GDEV. GDEV’s move has weight right now with tech stocks still strong, though the rally is uneven. The Nasdaq Composite was up 0.18% late Monday morning, as Nvidia and other big techs kept Wall Street close to record highs.
June 1, 2026
Intchains shares move higher with spotlight on Ethereum staking push
····

Intchains shares move higher with spotlight on Ethereum staking push

Intchains Group Limited shares traded higher in the U.S. Monday, beating out some other crypto-related stocks as buyers came back to the small-cap blockchain firm before its investor event set for later this week. American depositary shares were up 8.4% at $0.90, trading on volume of around 160,500 shares. The U.S.-traded certificates opened at $0.8751 and changed hands between $0.8119 and $0.90 so far.
June 1, 2026
Neogen Stock Slips as Food-Safety Turnaround Faces a Harder Test
····

Neogen Stock Slips as Food-Safety Turnaround Faces a Harder Test

Neogen Corp shares edged lower in Monday afternoon Nasdaq trading, lagging a firmer technology-led tape as investors kept the food- and animal-safety testing company in a holding pattern before its next operating update. The stock traded at $8.94, down about 0.4%, after moving between $8.75 and $9.15; its market value was about $1.94 billion, market data showed. The move was small. The message was not. Neogen is still being judged less on the day’s market mood than on whether it can turn Food Safety growth, cost cuts and a planned portfolio exit into steadier earnings.
June 1, 2026
Inovio Shares Fall After Analyst Cut, Traders Wait for FDA Decision
····

Inovio Shares Fall After Analyst Cut, Traders Wait for FDA Decision

Inovio Pharmaceuticals shares moved lower Monday after H.C. Wainwright trimmed its price target for the DNA-medicine firm. The call brought attention back to dilution and an upcoming U.S. regulatory ruling expected this year. INO was recently at $1.275, off 2.7%. More than 1 million shares traded hands. H.C. Wainwright cut its price target on the stock to $2.50 from $3.00 and kept a Neutral rating, market reports said. StreetInsider pointed to Raghuram Selvaraju as the analyst behind the move. Benzinga’s analyst-ratings page showed the firm made the target cut on June 1 and held its Neutral stance.
June 1, 2026
Airship AI Stock Moves in New York
···

Airship AI Stock Moves in New York

Airship AI Holdings shares rose a bit Monday, with the small-cap AI surveillance company staying on radar after recent earnings and new securities-registration filings turned the focus back to its government contract pipeline. The stock traded up 1.2% at $3.055, moving between $3.00 and $3.17 earlier. About 323,000 shares changed hands. The company’s market cap was close to $105 million.
June 1, 2026
Globalstar Trades Under Amazon’s $90 Bid With Confusing Deal Math
·····

Globalstar Trades Under Amazon’s $90 Bid With Confusing Deal Math

Globalstar shares were lower midday Monday, staying under the headline $90-a-share cash option in the Amazon.com buyout. Amazon shares also dropped, taking a toll on the stock part of the deal. Globalstar was at $83.31, off 1.1%. Amazon traded at $264.18, down 2.4%. This is important now because the deal is not a pure cash offer. Globalstar holders can choose $90 in cash or 0.3210 Amazon shares for each Globalstar share, but the shares are capped at $90 in value. Cash elections are limited to 40% of Globalstar shares. If more shareholders want cash, proration will scale it back.
June 1, 2026
Opus Genetics Slides Ahead of June Test
····

Opus Genetics Slides Ahead of June Test

Opus Genetics Inc. shares eased late Monday morning, retracing some of Friday’s advance. Investors are watching for the gene-therapy company’s slot at the Jefferies Global Healthcare Conference this week. The stock, which trades on the Nasdaq, slipped 7 cents to $4.29, off 1.6%. Shares opened at $4.40 and ranged from $4.20 to $4.49. Volume was roughly 288,500 shares. Market cap sat near $373 million.
June 1, 2026
ICF Stock Jumps Before Shareholder Vote as Rebound Case Gets Put to Test
····

ICF Stock Jumps Before Shareholder Vote as Rebound Case Gets Put to Test

ICF International shares rose 3.3% to $71.09 in late-morning Nasdaq trading on Monday, putting the government-services consultant ahead of its virtual annual meeting scheduled for Tuesday. The stock opened at $68.84, touched $71.73 and had traded 101,433 shares at the latest available quote, valuing the company at about $1.30 billion. Why now is simple enough: investors have one more trading session before the June 2 meeting, and online votes submitted before the meeting must be in by 11:59 p.m. ET on June 1. ICF says the meeting will be held online at 8:00 a.m. ET on Tuesday.
June 1, 2026
REGENXBIO Stock Barely Moves — The Gene-Therapy Test Wall Street Can’t Ignore
·····

REGENXBIO Stock Barely Moves — The Gene-Therapy Test Wall Street Can’t Ignore

REGENXBIO Inc shares were little changed in Monday morning trading, down about 0.6% at $6.97 at 10:47 a.m. EDT, as the small-cap gene-therapy developer moved without a new company-specific catalyst. The stock traded between $6.85 and $7.15, with a market value of about $365 million. Regular trading was under way on Nasdaq, whose U.S. market runs from 9:30 a.m. to 4 p.m. Eastern Time on standard weekdays. June 1 was not listed among Nasdaq’s 2026 market holidays.
June 1, 2026
Mobia Medical Drops Back Under IPO as Investors Question Stroke Device Plan
····

Mobia Medical Drops Back Under IPO as Investors Question Stroke Device Plan

Mobia Medical shares traded lower on Monday morning, as the stroke-recovery device maker stayed under its IPO price less than a month after listing on the Nasdaq. The stock last traded at $12.84, off 26 cents from Friday’s close. It moved between $12.71 and $13.32 earlier in the session. Mobia is in its first run as a public company. The IPO put 10 million shares on sale at $15 apiece and aimed to bring in roughly $150 million before fees and other costs.
June 1, 2026
Astronics shares edge lower after 20% share distribution news
····

Astronics shares edge lower after 20% share distribution news

Astronics Corporation shares slid Monday morning as the aerospace and defense electronics firm said it will distribute 20% Class B stock. That move adds a new corporate-action date for ATRO shareholders. The stock dropped $1.48, or around 1.7%, to $85.52. Shares traded in the $84.71 to $88.40 range earlier. Stock distribution set to shift Astronics holders’ portfolios. Shareholders of record on June 15 get one Class B share for every five common or Class B shares they own, Astronics said. Fractional shares will be paid out in cash, with distribution due around June 29.
June 1, 2026
Trident Digital Stock Slips After Nasdaq Reprieve — What TDTH Investors Are Watching Now
····

Trident Digital Stock Slips After Nasdaq Reprieve — What TDTH Investors Are Watching Now

Trident Digital Tech Holdings Ltd’s Nasdaq-listed American depositary shares, U.S.-traded certificates representing foreign shares, fell 1.9% to $2.52 in regular Monday trading, giving back ground after a week of listing-compliance news and AI partnership headlines. The ADSs opened at $2.58, touched $2.71, and traded as low as $2.52 on volume of 19,648 shares, market data showed. The move matters because the stock is now trading after a near-term Nasdaq threat was eased. Trident said last week that Nasdaq had confirmed the company regained compliance with the exchange’s $1 minimum bid price rule, a listing test based on whether a stock can keep its bid price above a required floor, and canceled a June 4 hearing. Chief Executive Soon Huat Lim
June 1, 2026
DLocal, June Payout in Focus After Shares Gain
····

DLocal, June Payout in Focus After Shares Gain

DLocal Limited shares traded a bit higher on Monday morning on the Nasdaq. The payments company’s upcoming June dividend date gave some investors a reason to watch after a shaky May. DLO was last seen at $11.91, up 5 cents, or around 0.4%, in a range between $11.81 and $12.08. Market cap stood near $3.53 billion. DLocal is still under the microscope on whether strong growth in payments volume will mean more profit now that a tax bill and rising costs hurt its first-quarter numbers. Wall Street kicked off June near all-time highs, but the Nasdaq Composite dipped 0.07% at the open, so DLocal’s early jump wasn’t just a tide-lift for tech.
June 1, 2026
Maravai Stock Dips Monday With Eyes on Major Event This Week
····

Maravai Stock Dips Monday With Eyes on Major Event This Week

Maravai LifeSciences Holdings shares slipped 0.6% to $4.77 in early Monday trading. The stock is still up nearly 9% for the last five sessions and up about 47% this year. The Nasdaq-listed life sciences name has turned into a recovery play after seeing a steep post-COVID pullback. That’s important now as the rebound’s early gains could be over. Investors want to see if demand for Maravai’s main businesses stays solid after one good quarter and a recent share rally.
June 1, 2026
Co-Diagnostics Shares Drop After New Resale Filing
····

Co-Diagnostics Shares Drop After New Resale Filing

Co-Diagnostics shares dropped hard on the Nasdaq in early trading Monday. It was the first regular session after the U.S. Securities and Exchange Commission made effective a resale registration statement linked to a recent private placement. The share price was at $6.71, down $1.83 from the $8.53 close on Friday. The stock swung between $5.11 and $10.18 during the session. The move pointed to high volatility in the small-cap diagnostics stock.
June 1, 2026
Pulmatrix Stock Slides As Eos Merger Clock Starts To Matter For PULM Holders
····

Pulmatrix Stock Slides As Eos Merger Clock Starts To Matter For PULM Holders

Pulmatrix Inc shares slipped in thin early Nasdaq trading on Monday, with the stock again moving around the planned merger with Eos SENOLYTIX rather than a fresh drug-data catalyst. The stock was quoted at $1.37, down 1.44%, at 09:30:01 a.m. ET, with volume of about 1,010 shares against a three-month average of roughly 50,490. Investing.com listed the company’s market value at about $5 million and its 52-week range at $1.16 to $9.23. The Nasdaq Composite was down 0.15% in the same market snapshot, while the S&P 500 was off 0.09%.
June 1, 2026
CGCT Heads Into Key Week With Factorial Deal Nearing Nasdaq Ticker Switch
·

CGCT Heads Into Key Week With Factorial Deal Nearing Nasdaq Ticker Switch

Cartesian Growth Corporation III was active premarket Monday after the SPAC dropped 7.19% to $12.53 Friday. Traders looked at the shareholder-backed merger with Factorial Inc., a solid-state battery maker, but heavy redemptions hit the deal. Premarket volume was light, and a market data feed had CGCT at $13.07 as of 8:10 a.m. EDT. Cartesian is now more than a blank-check company. The SPAC—essentially a listed cash shell set up to merge with a private firm—got shareholder approval for the Factorial deal at its May 27 special meeting. That cleared the main investor hurdle before the company can go ahead with shifting the listing.
June 1, 2026
Rezolute Shares Edge Higher Ahead of Key FDA Week
····

Rezolute Shares Edge Higher Ahead of Key FDA Week

Rezolute Inc. shares ticked up in premarket trading Monday, with the gain coming ahead of a scheduled appearance by company executives at a healthcare event later this week. The shares were at $3.30, up 4 cents, with the rare-disease drug maker’s market cap around $343 million. This was before the regular Nasdaq open; the exchange lists pre-market hours from 4:00 a.m. to 9:30 a.m. Eastern.
June 1, 2026
1 … 126 127 128 129 130 … 492